Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Earnings Preview: Capital Southwest (CSWC) Q4 Earnings Expected to Decline

Capital Southwest (CSWC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CSWC

Zacks Equity Research

Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MLAB

Zacks Equity Research

ProPetro Holding (PUMP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

ProPetro (PUMP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PUMP

Zacks Equity Research

Perceptron (PRCP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Perceptron (PRCP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRCP

Zacks Equity Research

Iteris (ITI) Expected to Beat Earnings Estimates: Should You Buy?

Iteris (ITI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ITI

Zacks Equity Research

All You Need to Know About Celyad SA (CYAD) Rating Upgrade to Strong Buy

Celyad SA (CYAD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CYAD

Zacks Equity Research

Constellation Pharmaceuticals, Inc. (CNST) Upgraded to Buy: What Does It Mean for the Stock?

Constellation Pharmaceuticals, Inc. (CNST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CNST

Zacks Equity Research

Bluebird (BLUE) Upgraded to Buy: What Does It Mean for the Stock?

Bluebird (BLUE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BLUE

Zacks Equity Research

Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: Here's What You Should Know

Applied Genetic Technologies (AGTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AGTC

Zacks Equity Research

Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?

Aduro Biotech (ADRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADRO

Zacks Equity Research

Earnings Preview: Conn's (CONN) Q1 Earnings Expected to Decline

Conn's (CONN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CONN

Zacks Equity Research

Circor (CIR) Reports Next Week: Wall Street Expects Earnings Growth

Circor (CIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CIR

Zacks Equity Research

Earnings Preview: Build-A-Bear (BBW) Q1 Earnings Expected to Decline

Build-A-Bear (BBW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BBW

Zacks Equity Research

Earnings Preview: Yamaha Motor Co., Ltd. (YAMHF) Q1 Earnings Expected to Decline

Yamaha Motor Co., Ltd. (YAMHF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

YAMHF

Zacks Equity Research

Earnings Preview: Genesco (GCO) Q1 Earnings Expected to Decline

Genesco (GCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GCO

Zacks Equity Research

Big Lots (BIG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Big Lots (BIG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BIG

Zacks Equity Research

Can Penn Virginia Corporation (PVAC) Run Higher on Rising Earnings Estimates?

Penn Virginia Corporation (PVAC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

PVAC

Zacks Equity Research

All You Need to Know About CheckCap Ltd. (CHEK) Rating Upgrade to Buy

CheckCap Ltd. (CHEK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CHEK

Zacks Equity Research

All You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong Buy

Bellicum Pharmaceuticals (BLCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

BLCM

Zacks Equity Research

All You Need to Know About Alexco Resource (AXU) Rating Upgrade to Strong Buy

Alexco Resource (AXU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AXU

Zacks Equity Research

American Renal Associates (ARA) Upgraded to Buy: Here's What You Should Know

American Renal Associates (ARA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ARA

Zacks Equity Research

Audioeye, Inc. (AEYE) Upgraded to Strong Buy: Here's Why

Audioeye, Inc. (AEYE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AEYE

Zacks Equity Research

Hamilton Lane (HLNE) Reports Next Week: Wall Street Expects Earnings Growth

Hamilton Lane (HLNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HLNE

Zacks Equity Research

Analysts Estimate Monro Muffler Brake (MNRO) to Report a Decline in Earnings: What to Look Out for

Monro (MNRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MNRO

Zacks Equity Research

Analysts Estimate Modine (MOD) to Report a Decline in Earnings: What to Look Out for

Modine (MOD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MOD